Ophthalmology News

Ophthal

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Nicoli P et al. – No reactivation of the Kaposi sarcoma found in a lymph node of one of the patients was observed. The report, along with additional data present in the literature, suggests that rituximab may be an appropriate and safe first–line therapy for HIV–negative, HHV8–positive MCD.


   

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address